Table 4.

Evolution of symptoms using a visual analogue scale—paired results.

	HIFU (N = 58)
	Mean ± SD (median)	[IQR]	(95% CI)
Gynaecological symptoms
Acute pelvic pain/dysmenorrhoea
Pre-op	6.2 ± 3.1 (7)	[5; 8.3]	(5.4; 7.0)
Six months	2.8 ± 3.0 (2)	[0; 5]	(2.0; 3.6)
Difference	−3.4 ± 3.8 (−3)	[−7; 0]	(−4.4; −2.4)
P-value	<0.001
Dyspareunia
Pre-op	4.7 ± 3.3 (6)	[0; 7.3]	(3.8; 5.6)
Six months	2.0 ± 2.9 (0)	[0; 3.3]	(1.3; 2.8)
Difference	−2.7 ± 3.3 (−3)	[−5.3; 0]	(−3.5; −1.8)
P-value	<0.001
Gastrointestinal symptoms
Diarrhoea
Pre-op	3.0 ± 3.3 (2.5)	[0; 6]	(2.2; 3.9)
Six months	1.2 ± 2.3 (0)	[0; 1.3]	(0.6; 1.8)
Difference	−1.9 ± 3.1 (0)	[−4; 0]	(−2.7; −1.1)
P-value	<0.001
Constipation
Pre-op	4.7 ± 3.7 (5.5)	[0; 8]	(3.7; 5.7)
Six months	2.2 ± 2.7 (0)	[0; 4]	(1.5; 2.9)
Difference	−2.5 ± 3.3 (−2)	[−4; 0]	(−3.4; −1.7)
P-value	<0.001
Rectal bleeding
Pre-op	1.1 ± 2.5 (0)	[0; 0]	(0.4; 1.7)
Six months	0.4 ± 1.6 (0)	[0; 0]	(0.0; 0.9)
Difference	−0.6 ± 2.6 (0)	[0; 0]	(−1.3; 0.0)
P-value	0.035
False urges
Pre-op	2.6 ± 3.0 (0)	[0; 5]	(1.8; 3.4)
Six months	0.6 ± 1.9 (0)	[0; 0]	(0.2; 1.1)
Difference	−1.9 ± 2.8 (0)	[−4; 0]	(−2.7; −1.2)
P-value	<0.001
Tenesmus/spasms
Pre-op	5.7 ± 3.0 (6)	[4.8; 8]	(4.9; 6.5)
Six months	2.8 ± 2.9 (3)	[0; 5]	(2.1; 3.6)
Difference	−2.8 ± 3.3 (−2.5)	[−6; 0]	(−3.7; −2.0)
P-value	<0.001
Pain on defecation
Pre-op	3.9 ± 3.7 (4)	[0; 7]	(2.9; 4.9)
Six months	1.3 ± 2.1 (0)	[0; 2.3]	(0.8; 1.9)
Difference	−2.6 ± 3.1 (−2)	[−5; 0]	(−3.4; −1.7)
P-value	<0.001
General symptoms
Post-pelvic pain
Pre-op	3.6 ± 3.8 (3)	[0; 7]	(2.6; 4.6)
Six months	2.1 ± 2.8 (0)	[0; 3.3]	(1.4; 2.8)
Difference	−1.5 ± 3.7 (0)	[−5; 0]	(−2.5; −0.5)
P-value	0.004
Asthenia
Pre-op	6.4 ± 2.6 (7)	[5; 8]	(5.7; 7.1)
Six months	4.2 ± 3.0 (4)	[1.8; 7]	(3.5; 5.0)
Difference	−2.1 ± 3.1 (−2)	[−4.3; 0]	(−2.9; −1.3)
P-value	<0.001

HIFU, high-intensity focused ultrasound; IQR, interquartile range.